Breaking News

China Biologic Receives Operating Permit

Shandong Taibang will commence plasma collection at its new branch collection facility

China Biologic has announced that their majority-owned subsidiary, Shandong Taibang, has recently received the operating permit from local authorities to commence plasma collection at its new branch collection facility in Ju County in Rizhao City, Shandong Province.

 

The new Ju County station covers a collection territory of approximately 3 million people, and the the new station is expected to reach its designed collection capacity in approximately three years.

 

Mr. David (Xiaoying) Gao, chairman and chief executive officer of China Biologic, said, “We are pleased to receive the operating permit and launch trial operations at our Ju County collection facility in Shandong Province. We also expect our new branch center in Feicheng County to complete its construction and obtain an operating permit in early 2018. Together with the other nine plasma collection stations we operate in Shandong Province, this new facility is expected to contribute to the overall growth of our plasma collection volume over time.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters